Advanced case of PKDL due to delayed treatment: A rare case report.

Clicks: 146
ID: 101052
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #92 of 102 articles by views in plos neglected tropical diseases

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Post-kala-azar dermal leishmaniasis (PKDL) is clinical outcome of visceral leishmaniasis (VL) and is thought to be the potential reservoir of parasite. Miltefosine (MF) is the only oral drug existing for treatment of post-kala-azar dermal leishmaniasis (PKDL). Increased miltefosine tolerance in clinical isolates of Leishmania donovani has been reported and is one of the major concerns in the treatment of PKDL. Here, we report a highly ulcerated PKDL case that was successfully cured after miltefosine treatment.
Reference Key
topno2020advancedplos Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Topno, Roshan Kamal;Rabi Das, Vidya Nand;Kumar, Maneesh;Madhukar, Major;Pandey, Krishna;Verma, Neena;Agrawal, Kanhaiya;Lal, Chandra Shekhar;Siddiqui, Niyamat Ali;Bimal, Sanjiva;Das, Pradeep;
Journal plos neglected tropical diseases
Year 2020
DOI
10.1371/journal.pntd.0008052
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.